Unique ID issued by UMIN | UMIN000011078 |
---|---|
Receipt number | R000012892 |
Scientific Title | Clinical study about the position verification using gold marker in the external irradiation combined I-125 brachytherapy for localized prostate cancer |
Date of disclosure of the study information | 2013/06/30 |
Last modified on | 2015/01/04 21:16:02 |
Clinical study about the position verification using gold marker in the external irradiation combined I-125 brachytherapy for localized prostate cancer
Clinical study about the position verification using gold marker in the external irradiation combined I-125 brachytherapy for localized prostate cancer
Clinical study about the position verification using gold marker in the external irradiation combined I-125 brachytherapy for localized prostate cancer
Clinical study about the position verification using gold marker in the external irradiation combined I-125 brachytherapy for localized prostate cancer
Japan |
Prostate cancer
Urology |
Malignancy
NO
To evaluate the accuracy of the position verification by linear gold marker in the external irradiation combined I-125 brachytherapy for patients with localized prostate cancer.
Safety,Efficacy
Confirmatory
Not applicable
The relative position error between the position coordinate and the reference CT image of the prostate as an index of the linear gold marker
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Linear gold marker is buried in the connective tissue both side of the prostate at seed implantation. CT imaging is acquired just after seed implantation. One month after seed implantation, the planning CT for external irradiation is imaged and is considered as a reference. External irradiation starts about one month after seed implantation. During the external irradiation, CT imaging is acquired once a week (five times in total).
35 | years-old | <= |
100 | years-old | > |
Male
1) Patients with intermediate/high risk group of localized prostate cancer to satisfy PSA>=10ng/ml or Gleason score>=7 or more than 34% positive biopsy core rate
2) Written informed consent must be obtained from patient
1) Patients less than 5 years life expectancy
2) Patients with distant metastases
3) Patients with gold allergy
4) Patients whom radiation therapy is contraindicated
5) Patients with bleeding tendency (including anticoagulant therapy)
6) Patients with ascites, pleural effusion
7) Parients suspeted with skin, pleura, peritoneum infection
8) Parients suspeted with abscess, vascular disease
9) Patients who can not be ensured a safe puncture route
10) Patients who can not be transfused
11) Patients whom target site is confusing
12) Patients who are judged inappropriate for the clinical trial by doctors
40
1st name | |
Middle name | |
Last name | Tomoya Kaneda |
National Hospital Organization Saitama Hosipital
radiology
2-1, Suwa, Wako-shi, Saitama
048-462-1101
tomoya_k54@yahoo.co.jp
1st name | |
Middle name | |
Last name | Tomoya Kaneda |
National Hospital Organization Saitama Hosipital
Radiology
2-1, Suwa, Wako-shi, Saitama
048-462-1101
tomoya_k54@yahoo.co.jp
National Hospital Organization Saitama Hosipital
National Hospital Organization Saitama Hosipital
Other
NO
国立病院機構埼玉病院(埼玉県)
2013 | Year | 06 | Month | 30 | Day |
Unpublished
Completed
2013 | Year | 06 | Month | 30 | Day |
2013 | Year | 07 | Month | 01 | Day |
2014 | Year | 06 | Month | 30 | Day |
2013 | Year | 06 | Month | 30 | Day |
2015 | Year | 01 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012892
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |